Stem cells from new automated platform in Florida could be used in Rochester.
Author’s archive
The development of 'cerebral organoids' from stem cells could impact the fight against Parkinson's disease.
RAEDI said its $1.5 million investment triggered $61 million in follow-on funding for local firms.
Indiana-based Recovery Force makes microprocessor-controlled compression wraps.
This is the second recent biotech investment from the young nonprofit.
Documents show the biotech incubator is seeking an 18,000-square-foot addition.
A Phase I study has opened for non-Hodgkin lymphoma and multiple myeloma patients.
Neurodegenerative and liver disease are among the targets of Regenerative Medicine Minnesota.
The Rochester-based health care provider and Veritas Genetics are launching an effort aimed at greatly extending WGS availability.
A preclinical study between Mayo and collaborator Corindus Vascular Robotics will test a remote-controlled ‘telestenting’ system in face of likely cardiologist shortfall.
University professor Jerrold Vitek and the MnDRIVE program were key in approval for Parkinson’s treatment.
An Aussie firm with a Twin Cities headquarters is using circadian waves to identify depression types.
Utilities say market forces and new technology, not politics,
have dethroned “King Coal.”
Its deal with a Singapore firm backs an AI platform to predict cardiac health events.
Workshops seek to give nurses tools to translate medtech ideas into reality.
The deal came as Rochester laundry was purchased by Wisconsin company.
Fundraising comes after positive pre-clinical results for its AnestaGel product.
Using OptumLab data, researchers found some anticoagulants are easier on kidneys.